The Trump administration’s decision to reclassify medical marijuana from Schedule I to Schedule III could quietly remake the Midwest cannabis landscape, even as prohibition holds firm in states like Wisconsin. The federal move leaves recreational marijuana untouched but opens the door for medical operators to access tax deductions, federal credits, and mainstream banking services that were largely off limits under Schedule I rules. Researchers will also benefit, no longer needing Schedule I licenses to study cannabis and gaining the ability to buy directly from medical growers.

Wisconsin remains an outlier: marijuana is still illegal, and criminal penalties for possession and distribution are unchanged despite pending legalization bills in Madison. Meanwhile, neighboring Illinois, Michigan and Minnesota continue to collect hundreds of millions in marijuana tax revenue, underscoring the stakes of Wisconsin’s go‑slow approach. For more details, see the original report from USA TODAY.